SZN-8141

Asset

Bifunctional Frizzled 4-mediated Wnt agonist and vascular endothelial growth factor antagonist antibody.

Stage
Phase 1
Modality
Antibody
Target
VEGFA
1
Indication
0
Trials
1
Developer

Indications

1

In the full profile

  • Targets and what it contains2
  • Owner and partners1
  • Evidence for its targets2
  • Competitors11

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets